Literature DB >> 17049609

Trans platinum complexes design: one novel water soluble oxime derivative that contains aliphatic amines in trans configuration.

Adoración G Quiroga1, Leticia Cubo, Elena de Blas, Patricio Aller, Carmen Navarro-Ranninger.   

Abstract

In an attempt to design new antitumoral drugs based on transplatin complexes, we determined the experimental conditions for the preparation of trans-[Pt((CH(3))(2)CNOH)((CH(3))(2)CHNH(2))Cl(2)], and solved the crystal structure. The cytotoxicity of the novel complex, the cis counterpart, cisplatin, and a trans complex with aliphatic amines, as well as the capacity of some of these complexes to cause either apoptotic or necrotic cell death, was comparatively examined in NRK-52E rat renal tubular cells and HepG2 human hepatoma cells. The results indicate that the oxime complex with trans geometry, but not the one with cis geometry, causes death by apoptosis, making the complex potentially suitable for therapeutic purposes. However cytotoxicity values are higher in the case of cis geometry than in trans geometry in both tumoral and non-tumoral cell lines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17049609     DOI: 10.1016/j.jinorgbio.2006.08.012

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  2 in total

1.  Cellular accumulation and DNA interaction studies of cytotoxic trans-platinum anticancer compounds.

Authors:  Caroline Bartel; Anna K Bytzek; Yulia Yu Scaffidi-Domianello; Gerlinde Grabmann; Michael A Jakupec; Christian G Hartinger; Markus Galanski; Bernhard K Keppler
Journal:  J Biol Inorg Chem       Date:  2012-01-07       Impact factor: 3.862

2.  Guanidine platinum(II) complexes: synthesis, in vitro antitumor activity, and DNA interactions.

Authors:  Anton A Legin; Michael A Jakupec; Nadezhda A Bokach; Marina R Tyan; Vadim Yu Kukushkin; Bernhard K Keppler
Journal:  J Inorg Biochem       Date:  2013-12-22       Impact factor: 4.155

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.